Annual D&A
$2.36 M
-$1.08 M-31.46%
December 31, 2023
Summary
- As of February 7, 2025, CORT annual depreciation & amortization is $2.36 million, with the most recent change of -$1.08 million (-31.46%) on December 31, 2023.
- During the last 3 years, CORT annual D&A has risen by +$125.00 thousand (+5.59%).
- CORT annual D&A is now -32.05% below its all-time high of $3.48 million, reached on December 31, 2021.
Performance
CORT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$499.00 K
+$301.00 K+152.02%
September 30, 2024
Summary
- As of February 7, 2025, CORT quarterly depreciation & amortization is $499.00 thousand, with the most recent change of +$301.00 thousand (+152.02%) on September 30, 2024.
- Over the past year, CORT quarterly D&A has increased by +$320.00 thousand (+178.77%).
- CORT quarterly D&A is now -59.23% below its all-time high of $1.22 million, reached on December 31, 2022.
Performance
CORT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.15 M
+$210.00 K+22.39%
September 30, 2024
Summary
- As of February 7, 2025, CORT TTM depreciation & amortization is $1.15 million, with the most recent change of +$210.00 thousand (+22.39%) on September 30, 2024.
- Over the past year, CORT TTM D&A has dropped by -$534.00 thousand (-31.75%).
- CORT TTM D&A is now -69.61% below its all-time high of $3.78 million, reached on June 30, 2023.
Performance
CORT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CORT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.5% | +178.8% | -31.8% |
| 3 y3 years | +5.6% | -59.2% | -66.7% |
| 5 y5 years | +900.9% | -59.2% | -66.7% |
CORT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | at low | -59.2% | +178.8% | -69.6% | +22.4% |
| 5 y | 5-year | -32.0% | +8.8% | -59.2% | +178.8% | -69.6% | +22.4% |
| alltime | all time | -32.0% | >+9999.0% | -59.2% | +263.1% | -69.6% | >+9999.0% |
Corcept Therapeutics Incorporated Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $499.00 K(+152.0%) | $1.15 M(+22.4%) |
| Jun 2024 | - | $198.00 K(+10.6%) | $938.00 K(-44.2%) |
| Mar 2024 | - | $179.00 K(-34.2%) | $1.68 M(-28.8%) |
| Dec 2023 | $2.36 M(-31.5%) | $272.00 K(-5.9%) | $2.36 M(-28.7%) |
| Sep 2023 | - | $289.00 K(-69.3%) | $3.31 M(-12.3%) |
| Jun 2023 | - | $942.00 K(+9.7%) | $3.78 M(+7.8%) |
| Mar 2023 | - | $859.00 K(-29.8%) | $3.50 M(+1.7%) |
| Dec 2022 | $3.45 M(-0.9%) | $1.22 M(+62.8%) | $3.45 M(+0.5%) |
| Sep 2022 | - | $752.00 K(+12.6%) | $3.43 M(-0.6%) |
| Jun 2022 | - | $668.00 K(-16.7%) | $3.45 M(-2.5%) |
| Mar 2022 | - | $802.00 K(-33.5%) | $3.54 M(+1.7%) |
| Dec 2021 | $3.48 M(+55.4%) | $1.21 M(+56.4%) | $3.48 M(+22.7%) |
| Sep 2021 | - | $771.00 K(+2.0%) | $2.83 M(+7.9%) |
| Jun 2021 | - | $756.00 K(+1.7%) | $2.63 M(+10.4%) |
| Mar 2021 | - | $743.00 K(+32.2%) | $2.38 M(+6.3%) |
| Dec 2020 | $2.24 M(+3.0%) | $562.00 K(-0.4%) | $2.24 M(+0.0%) |
| Sep 2020 | - | $564.00 K(+10.8%) | $2.24 M(-0.5%) |
| Jun 2020 | - | $509.00 K(-15.4%) | $2.25 M(-0.8%) |
| Mar 2020 | - | $602.00 K(+7.3%) | $2.26 M(+4.3%) |
| Dec 2019 | $2.17 M(+819.9%) | $561.00 K(-2.4%) | $2.17 M(+29.0%) |
| Sep 2019 | - | $575.00 K(+9.3%) | $1.68 M(+44.3%) |
| Jun 2019 | - | $526.00 K(+3.3%) | $1.17 M(+67.3%) |
| Mar 2019 | - | $509.00 K(+597.3%) | $697.00 K(+195.3%) |
| Dec 2018 | $236.00 K(+122.6%) | $73.00 K(+25.9%) | $236.00 K(+11.8%) |
| Sep 2018 | - | $58.00 K(+1.8%) | $211.00 K(+11.6%) |
| Jun 2018 | - | $57.00 K(+18.8%) | $189.00 K(+34.0%) |
| Mar 2018 | - | $48.00 K(0.0%) | $141.00 K(+33.0%) |
| Dec 2017 | $106.00 K(+21.8%) | $48.00 K(+33.3%) | $106.00 K(+45.2%) |
| Sep 2017 | - | $36.00 K(+300.0%) | $73.00 K(+25.9%) |
| Jun 2017 | - | $9000.00(-30.8%) | $58.00 K(-20.5%) |
| Mar 2017 | - | $13.00 K(-13.3%) | $73.00 K(-16.1%) |
| Dec 2016 | $87.00 K(-43.9%) | $15.00 K(-28.6%) | $87.00 K(-13.0%) |
| Sep 2016 | - | $21.00 K(-12.5%) | $100.00 K(-8.3%) |
| Jun 2016 | - | $24.00 K(-11.1%) | $109.00 K(-23.2%) |
| Mar 2016 | - | $27.00 K(-3.6%) | $142.00 K(-8.4%) |
| Dec 2015 | $155.00 K(+9.9%) | $28.00 K(-6.7%) | $155.00 K(-5.5%) |
| Sep 2015 | - | $30.00 K(-47.4%) | $164.00 K(-5.2%) |
| Jun 2015 | - | $57.00 K(+42.5%) | $173.00 K(+13.1%) |
| Mar 2015 | - | $40.00 K(+8.1%) | $153.00 K(+8.5%) |
| Dec 2014 | $141.00 K(+90.5%) | $37.00 K(-5.1%) | $141.00 K(+12.8%) |
| Sep 2014 | - | $39.00 K(+5.4%) | $125.00 K(+17.9%) |
| Jun 2014 | - | $37.00 K(+32.1%) | $106.00 K(+20.5%) |
| Mar 2014 | - | $28.00 K(+33.3%) | $88.00 K(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $74.00 K(+174.1%) | $21.00 K(+5.0%) | $74.00 K(+12.1%) |
| Sep 2013 | - | $20.00 K(+5.3%) | $66.00 K(+26.9%) |
| Jun 2013 | - | $19.00 K(+35.7%) | $52.00 K(+36.8%) |
| Mar 2013 | - | $14.00 K(+7.7%) | $38.00 K(+40.7%) |
| Dec 2012 | $27.00 K(+800.0%) | $13.00 K(+116.7%) | $27.00 K(+68.8%) |
| Sep 2012 | - | $6000.00(+20.0%) | $16.00 K(+60.0%) |
| Jun 2012 | - | $5000.00(+66.7%) | $10.00 K(+66.7%) |
| Mar 2012 | - | $3000.00(+50.0%) | $6000.00(+100.0%) |
| Dec 2011 | $3000.00(-50.0%) | $2000.00(>+9900.0%) | $3000.00(+200.0%) |
| Sep 2011 | - | $0.00(-100.0%) | $1000.00(-50.0%) |
| Jun 2011 | - | $1000.00(>+9900.0%) | $2000.00(-66.7%) |
| Dec 2010 | $6000.00(-40.0%) | $0.00(-100.0%) | $6000.00(-25.0%) |
| Sep 2010 | - | $1000.00(-50.0%) | $8000.00(-20.0%) |
| Jun 2010 | - | $2000.00(-33.3%) | $10.00 K(0.0%) |
| Mar 2010 | - | $3000.00(+50.0%) | $10.00 K(0.0%) |
| Dec 2009 | $10.00 K(-16.7%) | $2000.00(-33.3%) | $10.00 K(0.0%) |
| Sep 2009 | - | $3000.00(+50.0%) | $10.00 K(0.0%) |
| Jun 2009 | - | $2000.00(-33.3%) | $10.00 K(-16.7%) |
| Mar 2009 | - | $3000.00(+50.0%) | $12.00 K(0.0%) |
| Dec 2008 | $12.00 K(-7.7%) | $2000.00(-33.3%) | $12.00 K(-7.7%) |
| Sep 2008 | - | $3000.00(-25.0%) | $13.00 K(-7.1%) |
| Jun 2008 | - | $4000.00(+33.3%) | $14.00 K(+7.7%) |
| Mar 2008 | - | $3000.00(0.0%) | $13.00 K(0.0%) |
| Dec 2007 | $13.00 K(-7.1%) | $3000.00(-25.0%) | $13.00 K(-7.1%) |
| Sep 2007 | - | $4000.00(+33.3%) | $14.00 K(+7.7%) |
| Jun 2007 | - | $3000.00(0.0%) | $13.00 K(-7.1%) |
| Mar 2007 | - | $3000.00(-25.0%) | $14.00 K(0.0%) |
| Dec 2006 | $14.00 K(-98.0%) | $4000.00(+33.3%) | $14.00 K(-98.0%) |
| Sep 2006 | - | $3000.00(-25.0%) | $710.00 K(-0.1%) |
| Jun 2006 | - | $4000.00(+33.3%) | $711.00 K(+77.3%) |
| Mar 2006 | - | $3000.00(-99.6%) | $401.00 K(-43.0%) |
| Dec 2005 | $704.00 K(-56.3%) | $700.00 K(>+9900.0%) | $704.00 K(+95.0%) |
| Sep 2005 | - | $4000.00(-101.3%) | $361.00 K(-34.9%) |
| Jun 2005 | - | -$306.00 K(-200.0%) | $554.80 K(-60.4%) |
| Mar 2005 | - | $306.00 K(-14.3%) | $1.40 M(-13.0%) |
| Dec 2004 | $1.61 M(+7023.9%) | $357.00 K(+80.5%) | $1.61 M(+28.1%) |
| Sep 2004 | - | $197.80 K(-63.4%) | $1.26 M(+18.0%) |
| Jun 2004 | - | $540.20 K(+4.9%) | $1.06 M(+100.5%) |
| Mar 2004 | - | $515.00 K(>+9900.0%) | $531.20 K(+2250.4%) |
| Dec 2003 | $22.60 K | $4200.00(-25.0%) | $22.60 K(+22.8%) |
| Sep 2003 | - | $5600.00(-12.5%) | $18.40 K(+43.8%) |
| Jun 2003 | - | $6400.00(0.0%) | $12.80 K(+100.0%) |
| Mar 2003 | - | $6400.00 | $6400.00 |
FAQ
- What is Corcept Therapeutics Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual D&A year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly D&A year-on-year change?
- What is Corcept Therapeutics Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM D&A year-on-year change?
What is Corcept Therapeutics Incorporated annual depreciation & amortization?
The current annual D&A of CORT is $2.36 M
What is the all time high annual D&A for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual depreciation & amortization is $3.48 M
What is Corcept Therapeutics Incorporated annual D&A year-on-year change?
Over the past year, CORT annual depreciation & amortization has changed by -$1.08 M (-31.46%)
What is Corcept Therapeutics Incorporated quarterly depreciation & amortization?
The current quarterly D&A of CORT is $499.00 K
What is the all time high quarterly D&A for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly depreciation & amortization is $1.22 M
What is Corcept Therapeutics Incorporated quarterly D&A year-on-year change?
Over the past year, CORT quarterly depreciation & amortization has changed by +$320.00 K (+178.77%)
What is Corcept Therapeutics Incorporated TTM depreciation & amortization?
The current TTM D&A of CORT is $1.15 M
What is the all time high TTM D&A for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM depreciation & amortization is $3.78 M
What is Corcept Therapeutics Incorporated TTM D&A year-on-year change?
Over the past year, CORT TTM depreciation & amortization has changed by -$534.00 K (-31.75%)